From: Breast cancer care compared with clinical Guidelines: an observational study in France
Compliant | Justifiable | Non-compliant | Total* | ||||
---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | ||
Surgery | |||||||
Clinical decision | |||||||
Initial | 672 | (73) | 229 | (25) | 25 | (3) | 926 |
Complementary | 712 | (77) | 66 | (7) | 148 | (16) | 926 |
Procedure | |||||||
≥ 10 lymph nodes | 602 | (71) | 117 | (14) | 123 | (15) | 842 |
Complete resection | 716 | (78) | _ | _ | 198 | (22) | 914 |
Surgical staging | 903 | (99) | _ | _ | 11 | (1) | 914 |
Radiotherapy | |||||||
Clinical decision | |||||||
Breast or chest | 892 | (96) | 0 | (0) | 34 | (4) | 926 |
Axillary | 880 | (95) | 2 | (0) | 44 | (5) | 926 |
Internal mammary | 625 | (67) | 196 | (22) | 105 | (11) | 926 |
Supraclavicular | 627 | (68) | 165 | (18) | 134 | (14) | 926 |
Procedure | |||||||
Breast or chest | 696 | (77) | 165 | (18) | 41 | (5) | 902 |
Axillary | 38 | (73) | 8 | (15) | 6 | (11) | 52 |
Internal mammary | 376 | (74) | 111 | (22) | 20 | (4) | 507 |
Supraclavicular | 382 | (73) | 113 | (22) | 25 | (5) | 520 |
Time to radiotherapy | 568 | (62) | 30 | (3) | 313 | (34) | 911 |
Chemotherapy | |||||||
Clinical decision | 550 | (59) | 235 | (25) | 141 | (15) | 926 |
Procedure | |||||||
Protocols/cycles | 373 | (84) | 15 | (3) | 56 | (13) | 444 |
Time to chemotherapy | 355 | (80) | 33 | (7) | 56 | (13) | 444 |
Hormonal therapy | |||||||
Clinical decision | 822 | (89) | 19 | (2) | 85 | (9) | 926 |
Procedure | 616 | (92) | 29 | (4) | 25 | (4) | 670 |
Multidisciplinary meeting | 526 | (57) | 20 | (2) | 380 | (41) | 926 |